AMP-activated protein kinase: role in metabolism and therapeutic implications

AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes, obesity & metabolism obesity & metabolism, 2006-11, Vol.8 (6), p.591-602
Hauptverfasser: Schimmack, Greg, DeFronzo, Ralph A., Musi, Nicolas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 602
container_issue 6
container_start_page 591
container_title Diabetes, obesity & metabolism
container_volume 8
creator Schimmack, Greg
DeFronzo, Ralph A.
Musi, Nicolas
description AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and is involved in contraction‐stimulated glucose transport and fatty acid oxidation. In the heart, AMPK activity increases during ischaemia and functions to sustain ATP, cardiac function and myocardial viability. In the liver, AMPK inhibits the production of glucose, cholesterol and triglycerides and stimulates fatty acid oxidation. Recent studies have shown that AMPK is involved in the mechanism of action of metformin and thiazolidinediones, and the adipocytokines leptin and adiponectin. These data, along with evidence that pharmacological activation of AMPK in vivo improves blood glucose homeostasis, cholesterol concentrations and blood pressure in insulin‐resistant rodents, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes, ischaemic heart disease and other metabolic diseases.
doi_str_mv 10.1111/j.1463-1326.2005.00561.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68932924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68932924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4701-8a9dd795210b7ea9b115adfc545273e1ace1723240617c7c9eb1d0dc6049fb8c3</originalsourceid><addsrcrecordid>eNqNkMlOwzAQhi0EYim8AsqJW4K3xAniUlEoS8siQBwtx5kKt1lK7EL79riLyhVLlsfy_81YH0IBwRHx63wcEZ6wkDCaRBTjOPI7IdF8Bx1uH3ZXNQ3TDNMDdGTtGGPMWSr20QERmCY8ZYdo2B0-h0o7860cFMG0bRyYOpiYWlm4CNqmhMDfK3Aqb0pjq0DVReA-oVVTmDmjA1NNS6OVM01tj9HeSJUWTjZnB73fXL9d3YaDp_7dVXcQai4wCVOVFYXIYkpwLkBlOSGxKkY65jEVDIjSQARllOOECC10BjkpcKETzLNRnmrWQWfrvv6_XzOwTlbGaihLVUMzszJJM0Yzyn0wXQd121jbwkhOW1OpdiEJlkuVciyXxuTSmFyqlCuVcu7R082MWV5B8Qdu3PnA5TrwY0pY_Lux7D0NfeHxcI0b62C-xVU7kYlgIpYfj315__I26PHXvnxgv_xakUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68932924</pqid></control><display><type>article</type><title>AMP-activated protein kinase: role in metabolism and therapeutic implications</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Schimmack, Greg ; DeFronzo, Ralph A. ; Musi, Nicolas</creator><creatorcontrib>Schimmack, Greg ; DeFronzo, Ralph A. ; Musi, Nicolas</creatorcontrib><description>AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and is involved in contraction‐stimulated glucose transport and fatty acid oxidation. In the heart, AMPK activity increases during ischaemia and functions to sustain ATP, cardiac function and myocardial viability. In the liver, AMPK inhibits the production of glucose, cholesterol and triglycerides and stimulates fatty acid oxidation. Recent studies have shown that AMPK is involved in the mechanism of action of metformin and thiazolidinediones, and the adipocytokines leptin and adiponectin. These data, along with evidence that pharmacological activation of AMPK in vivo improves blood glucose homeostasis, cholesterol concentrations and blood pressure in insulin‐resistant rodents, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes, ischaemic heart disease and other metabolic diseases.</description><identifier>ISSN: 1462-8902</identifier><identifier>EISSN: 1463-1326</identifier><identifier>DOI: 10.1111/j.1463-1326.2005.00561.x</identifier><identifier>PMID: 17026483</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>ACC ; AMP-Activated Protein Kinases ; AMPK ; Blood Glucose - metabolism ; Diabetes Mellitus, Type 2 - physiopathology ; exercise ; Exercise - physiology ; glucose transport ; Heart Diseases - enzymology ; Humans ; Hypoglycemic Agents - pharmacology ; Lipid Metabolism - physiology ; Liver - metabolism ; Multienzyme Complexes - drug effects ; Multienzyme Complexes - physiology ; Muscle, Skeletal - enzymology ; Protein-Serine-Threonine Kinases - drug effects ; Protein-Serine-Threonine Kinases - physiology ; type 2 diabetes mellitus</subject><ispartof>Diabetes, obesity &amp; metabolism, 2006-11, Vol.8 (6), p.591-602</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4701-8a9dd795210b7ea9b115adfc545273e1ace1723240617c7c9eb1d0dc6049fb8c3</citedby><cites>FETCH-LOGICAL-c4701-8a9dd795210b7ea9b115adfc545273e1ace1723240617c7c9eb1d0dc6049fb8c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1463-1326.2005.00561.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1463-1326.2005.00561.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17026483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schimmack, Greg</creatorcontrib><creatorcontrib>DeFronzo, Ralph A.</creatorcontrib><creatorcontrib>Musi, Nicolas</creatorcontrib><title>AMP-activated protein kinase: role in metabolism and therapeutic implications</title><title>Diabetes, obesity &amp; metabolism</title><addtitle>Diabetes Obes Metab</addtitle><description>AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and is involved in contraction‐stimulated glucose transport and fatty acid oxidation. In the heart, AMPK activity increases during ischaemia and functions to sustain ATP, cardiac function and myocardial viability. In the liver, AMPK inhibits the production of glucose, cholesterol and triglycerides and stimulates fatty acid oxidation. Recent studies have shown that AMPK is involved in the mechanism of action of metformin and thiazolidinediones, and the adipocytokines leptin and adiponectin. These data, along with evidence that pharmacological activation of AMPK in vivo improves blood glucose homeostasis, cholesterol concentrations and blood pressure in insulin‐resistant rodents, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes, ischaemic heart disease and other metabolic diseases.</description><subject>ACC</subject><subject>AMP-Activated Protein Kinases</subject><subject>AMPK</subject><subject>Blood Glucose - metabolism</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>exercise</subject><subject>Exercise - physiology</subject><subject>glucose transport</subject><subject>Heart Diseases - enzymology</subject><subject>Humans</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Lipid Metabolism - physiology</subject><subject>Liver - metabolism</subject><subject>Multienzyme Complexes - drug effects</subject><subject>Multienzyme Complexes - physiology</subject><subject>Muscle, Skeletal - enzymology</subject><subject>Protein-Serine-Threonine Kinases - drug effects</subject><subject>Protein-Serine-Threonine Kinases - physiology</subject><subject>type 2 diabetes mellitus</subject><issn>1462-8902</issn><issn>1463-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMlOwzAQhi0EYim8AsqJW4K3xAniUlEoS8siQBwtx5kKt1lK7EL79riLyhVLlsfy_81YH0IBwRHx63wcEZ6wkDCaRBTjOPI7IdF8Bx1uH3ZXNQ3TDNMDdGTtGGPMWSr20QERmCY8ZYdo2B0-h0o7860cFMG0bRyYOpiYWlm4CNqmhMDfK3Aqb0pjq0DVReA-oVVTmDmjA1NNS6OVM01tj9HeSJUWTjZnB73fXL9d3YaDp_7dVXcQai4wCVOVFYXIYkpwLkBlOSGxKkY65jEVDIjSQARllOOECC10BjkpcKETzLNRnmrWQWfrvv6_XzOwTlbGaihLVUMzszJJM0Yzyn0wXQd121jbwkhOW1OpdiEJlkuVciyXxuTSmFyqlCuVcu7R082MWV5B8Qdu3PnA5TrwY0pY_Lux7D0NfeHxcI0b62C-xVU7kYlgIpYfj315__I26PHXvnxgv_xakUg</recordid><startdate>200611</startdate><enddate>200611</enddate><creator>Schimmack, Greg</creator><creator>DeFronzo, Ralph A.</creator><creator>Musi, Nicolas</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200611</creationdate><title>AMP-activated protein kinase: role in metabolism and therapeutic implications</title><author>Schimmack, Greg ; DeFronzo, Ralph A. ; Musi, Nicolas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4701-8a9dd795210b7ea9b115adfc545273e1ace1723240617c7c9eb1d0dc6049fb8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>ACC</topic><topic>AMP-Activated Protein Kinases</topic><topic>AMPK</topic><topic>Blood Glucose - metabolism</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>exercise</topic><topic>Exercise - physiology</topic><topic>glucose transport</topic><topic>Heart Diseases - enzymology</topic><topic>Humans</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Lipid Metabolism - physiology</topic><topic>Liver - metabolism</topic><topic>Multienzyme Complexes - drug effects</topic><topic>Multienzyme Complexes - physiology</topic><topic>Muscle, Skeletal - enzymology</topic><topic>Protein-Serine-Threonine Kinases - drug effects</topic><topic>Protein-Serine-Threonine Kinases - physiology</topic><topic>type 2 diabetes mellitus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schimmack, Greg</creatorcontrib><creatorcontrib>DeFronzo, Ralph A.</creatorcontrib><creatorcontrib>Musi, Nicolas</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes, obesity &amp; metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schimmack, Greg</au><au>DeFronzo, Ralph A.</au><au>Musi, Nicolas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AMP-activated protein kinase: role in metabolism and therapeutic implications</atitle><jtitle>Diabetes, obesity &amp; metabolism</jtitle><addtitle>Diabetes Obes Metab</addtitle><date>2006-11</date><risdate>2006</risdate><volume>8</volume><issue>6</issue><spage>591</spage><epage>602</epage><pages>591-602</pages><issn>1462-8902</issn><eissn>1463-1326</eissn><abstract>AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and is involved in contraction‐stimulated glucose transport and fatty acid oxidation. In the heart, AMPK activity increases during ischaemia and functions to sustain ATP, cardiac function and myocardial viability. In the liver, AMPK inhibits the production of glucose, cholesterol and triglycerides and stimulates fatty acid oxidation. Recent studies have shown that AMPK is involved in the mechanism of action of metformin and thiazolidinediones, and the adipocytokines leptin and adiponectin. These data, along with evidence that pharmacological activation of AMPK in vivo improves blood glucose homeostasis, cholesterol concentrations and blood pressure in insulin‐resistant rodents, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes, ischaemic heart disease and other metabolic diseases.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17026483</pmid><doi>10.1111/j.1463-1326.2005.00561.x</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1462-8902
ispartof Diabetes, obesity & metabolism, 2006-11, Vol.8 (6), p.591-602
issn 1462-8902
1463-1326
language eng
recordid cdi_proquest_miscellaneous_68932924
source MEDLINE; Access via Wiley Online Library
subjects ACC
AMP-Activated Protein Kinases
AMPK
Blood Glucose - metabolism
Diabetes Mellitus, Type 2 - physiopathology
exercise
Exercise - physiology
glucose transport
Heart Diseases - enzymology
Humans
Hypoglycemic Agents - pharmacology
Lipid Metabolism - physiology
Liver - metabolism
Multienzyme Complexes - drug effects
Multienzyme Complexes - physiology
Muscle, Skeletal - enzymology
Protein-Serine-Threonine Kinases - drug effects
Protein-Serine-Threonine Kinases - physiology
type 2 diabetes mellitus
title AMP-activated protein kinase: role in metabolism and therapeutic implications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A08%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AMP-activated%20protein%20kinase:%20role%20in%20metabolism%20and%20therapeutic%20implications&rft.jtitle=Diabetes,%20obesity%20&%20metabolism&rft.au=Schimmack,%20Greg&rft.date=2006-11&rft.volume=8&rft.issue=6&rft.spage=591&rft.epage=602&rft.pages=591-602&rft.issn=1462-8902&rft.eissn=1463-1326&rft_id=info:doi/10.1111/j.1463-1326.2005.00561.x&rft_dat=%3Cproquest_cross%3E68932924%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68932924&rft_id=info:pmid/17026483&rfr_iscdi=true